Cargando…
A Review of Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Breast Cancer
Breast cancer (BC) has a high mortality rate and metastatic BC is almost incurable despite hormonal therapy and chemotherapy. The second and third lines of chemotherapies usually yield transient responses and the median survival is generally as low as 18-24 months. Autologous and allogeneic hematopo...
Autores principales: | Karadurmus, Nuri, Sahin, Ugur, Bahadir Basgoz, Bilgin, Arpaci, Fikret, Demirer, Taner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141428/ https://www.ncbi.nlm.nih.gov/pubmed/30233772 |
Ejemplares similares
-
Review of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in solid tumors excluding breast cancer
por: Karadurmus, Nuri, et al.
Publicado: (2016) -
Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements
por: Ocal, Nesrin, et al.
Publicado: (2016) -
A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
por: Atilla, Erden, et al.
Publicado: (2017) -
Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation
por: Atilla, Erden, et al.
Publicado: (2017) -
Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation
por: Cengiz Seval, Güldane, et al.
Publicado: (2018)